Want to see OPRX full AI Analyst Report?
OPRX Stock Chart & Stats
$6.24
$0.11(1.76%)
At close: 4:00 PM EDT
$6.24
$0.11(1.76%)
Day’s Range― - ―
52-Week Range$4.54 - $22.25
Previous CloseN/A
Volume41.31K
Average Volume (3M)393.42K
Market Cap
$113.53M
Enterprise Value$121.37
Total Cash (Recent Filing)$20.17M
Total Debt (Recent Filing)$23.72M
Price to Earnings (P/E)16.5
Beta1.92
Next Earnings
Aug 12, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.36
Shares Outstanding18,765,076
10 Day Avg. Volume233,316
30 Day Avg. Volume393,417
Financial Highlights & Ratios
PEG Ratio-0.35
Price to Book (P/B)1.77
Price to Sales (P/S)2.08
P/FCF Ratio12.19
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$12.00Price Target Upside92.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.94
Revenue Forecast (FY)$97.41M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and a sizeable equity base provide durable financial flexibility. This reduces refinancing and solvency risk, supports investment in product development and programmatic initiatives, and cushions the business through client or revenue volatility over the next 2–6 months.
Improved And Sustainable MarginsHigh gross margins and meaningful operating margin expansion reflect scalable, software-like economics and successful cost optimization. Margin resilience supports cash generation, funds reinvestment into growth channels, and makes earnings less sensitive to near-term top-line softness.
Product Traction And Recurring Revenue GrowthStrong DAP growth and rising subscription mix indicate improving product-market fit and more predictable revenue. Increasing recurring revenue and higher ARPU among top clients support longer-term revenue visibility as programmatic and subscription penetration scales into underused EHR inventory.
Bears Say
Top-line Decline And Lowered Revenue GuidanceA meaningful YoY revenue decline and downward guidance signal durable near-term demand weakness for some services. Even with margin gains, slower revenue undermines the ability to scale sales and product investments and may delay recovery to prior growth trajectories over the next several quarters.
Contracted Revenue And Visibility PressureMaterially lower contracted revenue and shorter contract durations reduce forward revenue visibility and weaken predictability of renewals. That constrains planning and delays realization of programmatic/DSP scale benefits, making near-term cash flow and growth timing more uncertain.
Customer Concentration RiskHigh revenue concentration leaves results vulnerable to budget shifts or sourcing changes at a few large clients. The pack also cites a major client disruption, showing this is a realized risk that can materially affect revenue and visibility if renewals or MFN-related pressures persist.
OptimizeRx News
OPRX FAQ
What was Optimizerx Corporation’s price range in the past 12 months?
Optimizerx Corporation lowest stock price was $4.54 and its highest was $22.25 in the past 12 months.
What is Optimizerx Corporation’s market cap?
Optimizerx Corporation’s market cap is $113.53M.
When is Optimizerx Corporation’s upcoming earnings report date?
Optimizerx Corporation’s upcoming earnings report date is Aug 12, 2026 which is in 9 days.
How were Optimizerx Corporation’s earnings last quarter?
Optimizerx Corporation released its earnings results on May 12, 2026. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.053 by $0.087.
Is Optimizerx Corporation overvalued?
According to Wall Street analysts Optimizerx Corporation’s price is currently Undervalued.
Does Optimizerx Corporation pay dividends?
Optimizerx Corporation does not currently pay dividends.
What is Optimizerx Corporation’s EPS estimate?
Optimizerx Corporation’s EPS estimate is 0.11.
How many shares outstanding does Optimizerx Corporation have?
Optimizerx Corporation has 18,765,076 shares outstanding.
What happened to Optimizerx Corporation’s price movement after its last earnings report?
Optimizerx Corporation reported an EPS of $0.14 in its last earnings report, beating expectations of $0.053. Following the earnings report the stock price went down -22.476%.
Which hedge fund is a major shareholder of Optimizerx Corporation?
Currently, no hedge funds are holding shares in OPRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OptimizeRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (92.31% Upside)
$12.00 (92.31% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 206.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.30%
Trailing 12-Months
Company Description
Optimizerx Corporation
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
OPRX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced encouraging operational and margin progress (strong adjusted EBITDA growth, improved gross margins, significant product traction with DAP and subscription growth, refinancing savings, and KPI improvements) against tangible near-term top-line challenges (10% YoY revenue decline, 15-20% contracted revenue shortfall, a major client disruption, reduced cash and negative operating cash flow, and a downward revision to revenue guidance). Management emphasized these headwinds are short-to-intermediate term and highlighted programmatic/DSP initiatives and subscription mix as drivers for 2027 recovery.View all OPRX earnings summariesOPRX Stock 12 Month Forecast
Average Price Target
$12.00
▲(92.31% Upside)
Technical Analysis
Ownership Overview
7.57% Insiders
15.33% Mutual Funds
1.38% Other Institutional Investors
70.44% Public Companies and
Individual Investors